Altimmune's Earnings Outlook
Portfolio Pulse from Benzinga Insights
Altimmune (NASDAQ:ALT) is set to release its quarterly earnings report on November 7, 2023. Analysts estimate an earnings per share (EPS) of $-0.42. The company's past performance shows a pattern of beating EPS estimates but experiencing a drop in share price. Over the last 52-week period, shares are down 74.4%.
November 06, 2023 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Altimmune's upcoming earnings report could impact its stock price. Despite beating EPS estimates in the past, the company's share price has generally dropped. Over the last year, shares are down 74.4%.
Altimmune's stock price has generally dropped despite beating EPS estimates in the past. This trend, combined with the overall negative return over the past year, suggests that the upcoming earnings report could negatively impact the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100